Zohar Sachs

I am thrilled to share our latest work in @CellStemCell which discovers that 5q deletion of lamin B1 in myeloid malignancies drives nuclear anomaly and altered HSC function, led by @andreeareilly. Tweetorial and share link below. cell.com/cell-stem-cell…

My #ASH23 highlight: watching my fantastic student, @YoonkyuLee020, present a new scRNA seq analysis method that he developed with terrific collaborator, Chad Myers, (paper 0241).

Beautiful talk using forward genetic screen to identify ERG as a major contributor MDS progression to secondary AML in the mutant p53/(del5q) settings. @SachsZohar #Ash2023

Meanwhile the @umnmedschool @MHealthFairview physicians and staff are focused and working very hard. We just quietly became the allogeneic #BMT program with the best survival outcomes in the state despite fewer resources. Why? Our RESEARCH. startribune.com/documents-show…

Tom on #HealthcareUnfiltered, I host ⁦@lbaughn⁩ & ⁦@akkari_yassmine⁩ two dedicated scientists to tackle & simplify the topic of “Cytogenetics and Cancer.” How did molecular genetics & cancer geneticists change our understanding of cancer? Critical topic; airs in am.

Excited to be performing again at the Cowles Center!!!

We passed the PRO Act off the Senate floor! After 15 hours of debate, we are tired but jubilant. When @GovTimWalz signs it, the right to make individual, autonomous decisions about reproductive healthcare, including abortion, will be codified into Minnesota law. #PROAct

Our new manuscript, kudos to @MikkaelSekeres leading this effort and grateful to the FDA vision to get this panel together. Considerations for Drug Development in Myelodysplastic Syndromes aacrjournals.org/clincancerres/… @Dr_AmerZeidan @AmyDeZern @KellyNorsworth2 @NinaKimMD

Considerations for drug development in #MDS ⁦@CCR_AACR⁩ aacrjournals.org/clincancerres/…

A big part of the scientific process is just having someone to talk to. If you can spare a few minutes, ask a colleague what they're working on..

So excited to have NK cell expert and UMN Heme/Onc/Transplant alum, @romeerizwan back in Minnesota today! Looking forward to a terrific talk and catching up with a dear friend #bmt

Stanley Adoro, #aacrAMLMDS cochair @RaviMajetiMD, Eric R. Lechman, and @DrMonicaGuzman discussed Stem Cells in a plenary session at the AACR Special Conference on Acute Myeloid Leukemia and Myelodysplastic Syndrome today in Austin, Texas.

Outstanding presentation by @DrMonicaGuzman. An exciting role for the epichaperone in treating AML. Careful, well designed studies of a single patient can teach us a lot

Excited for @AACR Special Conference on AML and MDS! #aacrAMLMDS aacr.org/meeting/acute-…

Wow! Coverage of the IPSS-M publication during #EHA22 ranked as the top 1 most viewed conference content in 2022 by the #AJMC ajmc.com/view/top-5-mos… @Elsa2Bernard

Dr. Shernan Holtan (@sghmd) discusses her research into a pregnancy hormone that may hold the key to treating life-threatening graft-vs-host diseases and how Teiko helped her overcome the barriers to high-dimensional immune profiling. hubs.ly/Q01xNLW60

And how is your PhD going?

Amazing great news for GVHD prophy! One of my favorite moments at ASH to see one of smartest and nicest hematologist presenting these exciting results so elegantly!!! Way to go Shernan!!! @sghmd @UMNCancer #ASH22